Polmann, L., Schliemann, C., Sgonina, L. M., Heptner, B., Eisfeld, C., Marx, J., Mikesch, J.-H., Reicherts, C., Bleckmann, A., Lenz, G., Stelljes, M. and Wethmar, K. (2020) “Measurable residual disease-negative remission of BRAF-V600Emutated acute myeloid leukemia with dabrafenib and trametinib”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301553.